Wilcox CR, et al. Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant Women and Healthcare Professionals. Pediatr Infect Dis J. 2018 Nov 9
INTRODUCTION:
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the acceptability of routine vaccination among pregnant women, (2) the confidence of maternity healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the optimum healthcare site for vaccine administration.
METHODS:
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts in South England (July 2017-January 2018).
RESULTS:
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 78% and 92%, respectively. The commonest reason for declining vaccination was feared side-effects for their child. White British women (79%) were significantly more accepting of influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 1.77-13.19) compared with non-white-British women. Among HCPs, 25% were slightly or not-at-all confident discussing vaccination. Obstetricians felt significantly more confident discussing pertussis vaccination than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-4.12). Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary care (general practice), community midwifery and in hospital, respectively.
CONCLUSION:
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information towards the child´s safety may increase uptake. Education of HCPs is essential, and vaccine promotion should be incorporated into routine antenatal care, with an emphasis on women from ethnic minorities. Administration of vaccines in primary care presents logistical barriers however support for alternative sites appears low among HCPs.
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the acceptability of routine vaccination among pregnant women, (2) the confidence of maternity healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the optimum healthcare site for vaccine administration.
METHODS:
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts in South England (July 2017-January 2018).
RESULTS:
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 78% and 92%, respectively. The commonest reason for declining vaccination was feared side-effects for their child. White British women (79%) were significantly more accepting of influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 1.77-13.19) compared with non-white-British women. Among HCPs, 25% were slightly or not-at-all confident discussing vaccination. Obstetricians felt significantly more confident discussing pertussis vaccination than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-4.12). Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary care (general practice), community midwifery and in hospital, respectively.
CONCLUSION:
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information towards the child´s safety may increase uptake. Education of HCPs is essential, and vaccine promotion should be incorporated into routine antenatal care, with an emphasis on women from ethnic minorities. Administration of vaccines in primary care presents logistical barriers however support for alternative sites appears low among HCPs.
See Also:
Latest articles in those days:
- Highly pathogenic avian influenza as a systemic risk - implications for control and preparedness 20 hours ago
- Multiple introductions and spread of novel reassortant highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b viruses via wild birds, South Korea, 2024-2025 20 hours ago
- [preprint]The mammalian-adaptive PB2-E627K substitution preserves viral fitness of clade 2.3.4.4b H5N1 HPAIV in birds 1 days ago
- Mallard super-shedders of avian influenza exhibit distinct cloacal microbial abundance profiles 2 days ago
- A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge 2 days ago
[Go Top] [Close Window]


